Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product. Pergolizzi JV Jr, Taylor R Jr, LeQuang JA, Raffa RB. J Pain Res. 2018 Feb 8;11:301-311. doi: 10.21...

Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder. Shi Z, Wang AL, Jagannathan K, Fairchild VP, O'Brien CP, Childress AR, Langleben DD. J Psychiatry Neurosci. 2018 Feb 23;43...

Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry. Saxon AJ, Akerman SC, Liu CC, Sullivan MA, Silverman BL, Vocci FJ. Addiction. 2018 Mar 1. doi: 10.1111/add.14199....

Could Naltrexone Be Used to Treat Pregnant Women with Opioid Addiction? Of the three medications currently approved to treat opioid addiction, the long-acting antagonist naltrexone, which blocks opioids from attaching to the mu-opioid receptor, i...

USA. SAMHSA publishes guidance on clinical best practices using medication-assisted treatment to combat the opioid epidemic The Substance Abuse and Mental Health Services Administration (SAMHSA) is publishing guidance today to help broaden health...

USA-SAMHSA. TIP 63: Medications for Opioid Use Disorders – Full Document (Including Executive Summary and Parts 1-5) This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medicati...